Show simple item record

dc.contributor.editorHaskett, Dorothy Reganen_US
dc.creatorFlorez, Chase V.
dc.date.accessioned2019-12-01T02:35:33Z
dc.date.available2019-12-01T02:35:33Z
dc.date.created2019-11-30
dc.identifier.urihttps://hpsrepository.asu.edu/handle/10776/13141
dc.description.abstractIn 1994, Edward M. Connor and colleagues published “Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment.” Their study summarized how to reduce the transfer of human immunodeficiency virus, or HIV, from pregnant women to their fetuses with Zidovudine, otherwise known as AZT. HIV is a virus that weakens the immune system by destroying white blood cells, a part of the body’s immune system. Fifteen to forty percent of infants born to HIV-positive mothers become infected during fetal development, labor and delivery, or breast-feeding. From April 1991 to December 1993, Connor and his colleagues researched HIV-positive pregnant women who took AZT, a drug that treats but does not cure an HIV infection. In their article, Conner and colleagues showed that AZT decreased the maternal-infant transmission of HIV and helped decrease infant mortality due to the viral infection.en_US
dc.format.mediumtext/xhtmlen_US
dc.language.isoen_USen_US
dc.language.isoen_USen_US
dc.publisherArizona State University. School of Life Sciences. Center for Biology and Society. Embryo Project Encyclopedia.en_US
dc.relation.ispartofEmbryo Project Encyclopediaen_US
dc.rightsCopyright Arizona Board of Regentsen_US
dc.subjectLiteratureen_US
dc.subject.lcshHIV-positive personsen_US
dc.subject.lcshHIV infectionsen_US
dc.subject.lcshHIV-positive womenen_US
dc.subject.lcshHIV-positive childrenen_US
dc.subject.lcshUNFPA/UNICEF/WHO/UNAIDS Inter-Agency Task Team on Mother-to-Child Transmission of HIVen_US
dc.subject.lcshMinistry of Health and Child Welfare, Prevention of Mother to Child Transmission of HIVen_US
dc.subject.lcshHIV infections--Preventionen_US
dc.subject.lcshHIV infections--Complicationsen_US
dc.subject.meshDisease Transmission, Infectiousen_US
dc.subject.meshInfectious Disease Transmission, Verticaen_US
dc.subject.meshHIV Infectionsen_US
dc.subject.meshAIDS Serodiagnosisen_US
dc.subject.meshZidovudineen_US
dc.subject.meshHIV Infectionsen_US
dc.titleReduction of Maternal-Infant Transmission of Human Immunodeficiency Virus with Zidovudine Treatmenten_US
dc.typeArticleen_US
dc.typeTexten_US
dc.rights.licenseLicensed as Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported (CC BY-NC-SA 3.0) http://creativecommons.org/licenses/by-nc-sa/3.0/en_US
dc.subject.embryoPublicationsen_US
dc.subject.tagHuman immunodifiency virus - HIVen_US
dc.subject.tagPrenatal effectsen_US
dc.subject.tagMaternal Transmissionen_US
dc.subject.tagZidovudineen_US
dc.description.typeArticlesen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record